HK1003003A1 - Novel compositions containing hyaluronic acid associates and a process for preparing same - Google Patents

Novel compositions containing hyaluronic acid associates and a process for preparing same

Info

Publication number
HK1003003A1
HK1003003A1 HK98102052A HK98102052A HK1003003A1 HK 1003003 A1 HK1003003 A1 HK 1003003A1 HK 98102052 A HK98102052 A HK 98102052A HK 98102052 A HK98102052 A HK 98102052A HK 1003003 A1 HK1003003 A1 HK 1003003A1
Authority
HK
Hong Kong
Prior art keywords
hyaluronic acid
compositions containing
novel compositions
preparing same
containing hyaluronic
Prior art date
Application number
HK98102052A
Other languages
English (en)
Inventor
Kalman Burger
Nagy Geza Takacsi
Ivan Rethey
Janos Illes
Bela Stefko
Erzsebet Neszmelyi
Istvan Gebhardt
Istvan Racz
Arpadne Kiraly
Viktoria Varkonyi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of HK1003003A1 publication Critical patent/HK1003003A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK98102052A 1989-02-24 1998-03-12 Novel compositions containing hyaluronic acid associates and a process for preparing same HK1003003A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU89891A HU203372B (en) 1989-02-24 1989-02-24 Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
PCT/HU1990/000013 WO1990010020A1 (en) 1989-02-24 1990-02-20 Novel compositions containing hyaluronic acid associates and a process for preparing same

Publications (1)

Publication Number Publication Date
HK1003003A1 true HK1003003A1 (en) 1998-09-30

Family

ID=10951903

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102052A HK1003003A1 (en) 1989-02-24 1998-03-12 Novel compositions containing hyaluronic acid associates and a process for preparing same

Country Status (33)

Country Link
US (1) US5554598A (ru)
EP (1) EP0413016B1 (ru)
JP (1) JP2571312B2 (ru)
KR (1) KR960015624B1 (ru)
CN (2) CN1024557C (ru)
AR (1) AR243538A1 (ru)
AT (1) ATE98964T1 (ru)
AU (1) AU623232B2 (ru)
BG (1) BG61515B2 (ru)
CA (1) CA2027596C (ru)
CZ (1) CZ281000B6 (ru)
DD (1) DD292263A5 (ru)
DE (1) DE69005394T2 (ru)
DK (1) DK0413016T3 (ru)
ES (1) ES2061016T3 (ru)
FI (1) FI101707B1 (ru)
GE (2) GEP19981358B (ru)
GR (1) GR1000869B (ru)
HK (1) HK1003003A1 (ru)
HU (2) HU203372B (ru)
IE (1) IE62408B1 (ru)
IL (1) IL93489A (ru)
LT (2) LT3806B (ru)
LV (2) LV10112B (ru)
MY (1) MY105168A (ru)
NO (1) NO301169B1 (ru)
PL (1) PL163417B1 (ru)
PT (1) PT93237B (ru)
RU (2) RU2099350C1 (ru)
SK (1) SK85790A3 (ru)
UA (2) UA26324A (ru)
WO (1) WO1990010020A1 (ru)
ZA (1) ZA901357B (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR920100122A (el) * 1991-04-05 1993-03-16 Ethicon Inc Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
DE4115454A1 (de) * 1991-05-11 1992-11-12 Basf Ag Eisen-(iii)-hyaluronate
US5531716A (en) * 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
CN1064372C (zh) * 1994-08-26 2001-04-11 顾其胜 透明质酸钠制剂的制备方法
US6368356B1 (en) 1996-07-11 2002-04-09 Scimed Life Systems, Inc. Medical devices comprising hydrogel polymers having improved mechanical properties
HU225991B1 (en) * 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US7192984B2 (en) 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
JP2003089647A (ja) 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6913765B2 (en) 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
CZ12015U1 (cs) * 2002-01-18 2002-02-25 Cpn Spol. S R.O. Přípravek pro prevenci adheze bandáľe na ránu
WO2004024197A1 (en) 2002-09-11 2004-03-25 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
JPWO2006121210A1 (ja) * 2005-05-13 2008-12-18 高田製薬株式会社 皮膚状態改善剤
WO2006121209A1 (ja) * 2005-05-13 2006-11-16 Takata Seiyaku Co., Ltd. 湿疹・皮膚炎群治療剤
JP4220513B2 (ja) * 2005-12-01 2009-02-04 株式会社資生堂 カチオン化ヒアルロン酸
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
FR2918565B1 (fr) * 2007-07-12 2009-10-30 Biopharmex Holding Sa Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
ES2326721B1 (es) * 2008-01-04 2010-07-16 Endor Nanotechnologies, S.L. Conjugado de acido hialuronico para el tratamiento cosmetico y procedimiento de preparacion.
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
EP2559708B1 (en) * 2010-04-14 2018-06-20 Kewpie Corporation Process for producing zinc hyaluronate, process for producing cosmetic containing zinc hyaluronate, zinc hyaluronate and process for producing the same
ES2376680B8 (es) 2010-08-16 2013-04-30 Nylstar, S.A. Fibra textil cosmética, procedimiento de obtención y su empleo.
CN102552309B (zh) * 2010-12-15 2013-06-05 北京理工大学 一种透明质酸金的用途及其制备方法
JP5763953B2 (ja) * 2011-03-31 2015-08-12 ロート製薬株式会社 外用組成物
CN102961396A (zh) * 2012-12-17 2013-03-13 程玉李 透明质酸金属盐在制备治疗皮肤病药物中的应用、其药物组合物及其制备方法
ES2908345T3 (es) 2013-11-03 2022-04-28 Univ California Líquidos iónicos para la administración transdérmica de medicamentos
WO2018044920A1 (en) * 2016-08-29 2018-03-08 The Regents Of The University Of California Topical formulations based on ionic species for skin treatment
US10898613B2 (en) 2016-09-21 2021-01-26 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent zinc cation
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa HYALURONIC ACID GEL WITH A DIVALENT CATION
PE20211202A1 (es) 2017-08-24 2021-07-05 Novo Nordisk As Composiciones de glp-1 y sus usos
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations
CN111647100B (zh) * 2020-07-14 2022-03-01 山东华熙海御生物医药有限公司 一种高分子量透明质酸锌的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441973A (en) 1890-12-02 rapieff
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
HU172831B (hu) * 1976-03-31 1978-12-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
US4303676A (en) 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US4623539A (en) 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
NO161573C (no) 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
JPS61286310A (ja) * 1985-06-10 1986-12-16 Kanebo Ltd メ−クアツプ化粧料
AU600483B2 (en) * 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
US4742215A (en) * 1986-05-07 1988-05-03 Personal Computer Card Corporation IC card system
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes

Also Published As

Publication number Publication date
EP0413016A1 (en) 1991-02-20
IE62408B1 (en) 1995-01-25
GEP19981358B (en) 1998-08-25
AU623232B2 (en) 1992-05-07
PT93237A (pt) 1990-08-31
JPH03505231A (ja) 1991-11-14
JP2571312B2 (ja) 1997-01-16
AR243538A1 (es) 1993-08-31
CA2027596C (en) 2001-01-02
UA26324A (uk) 1999-08-30
SK279530B6 (sk) 1998-12-02
CN1051228C (zh) 2000-04-12
MY105168A (en) 1994-08-30
FI101707B (fi) 1998-08-14
PL163417B1 (pl) 1994-03-31
IE900637L (en) 1990-08-24
ES2061016T3 (es) 1994-12-01
KR960015624B1 (ko) 1996-11-18
NO904584L (no) 1990-12-21
LV10112B (en) 1995-02-20
NO904584D0 (no) 1990-10-23
ATE98964T1 (de) 1994-01-15
FI101707B1 (fi) 1998-08-14
UA39174C2 (ru) 2001-06-15
AU5108890A (en) 1990-09-26
LTIP1474A (en) 1995-06-26
SK85790A3 (en) 1998-12-02
EP0413016B1 (en) 1993-12-22
CZ281000B6 (cs) 1996-05-15
PT93237B (pt) 1996-01-31
CN1045394A (zh) 1990-09-19
IL93489A (en) 1994-05-30
LT3806B (en) 1996-03-25
CN1024557C (zh) 1994-05-18
LT3873B (en) 1996-04-25
US5554598A (en) 1996-09-10
DK0413016T3 (da) 1994-02-14
PL283942A1 (en) 1991-01-28
DD292263A5 (de) 1991-07-25
GR1000869B (el) 1993-03-16
BG61515B2 (bg) 1997-10-31
LV10965A (lv) 1995-12-20
NO301169B1 (no) 1997-09-22
HU211465A9 (en) 1995-11-28
GEP19971015B (en) 1997-05-30
HU203372B (en) 1991-07-29
GR900100137A (en) 1991-06-28
HUT53128A (en) 1990-09-28
DE69005394T2 (de) 1994-07-28
DE69005394D1 (de) 1994-02-03
LTIP1418A (en) 1995-05-25
WO1990010020A1 (en) 1990-09-07
RU2021304C1 (ru) 1994-10-15
CN1086422A (zh) 1994-05-11
CA2027596A1 (en) 1990-08-25
ZA901357B (en) 1990-11-28
CZ85790A3 (en) 1995-02-15
RU2099350C1 (ru) 1997-12-20
KR920700231A (ko) 1992-02-19
LV10965B (en) 1996-08-20
LV10112A (lv) 1994-05-10
FI905109A0 (fi) 1990-10-17

Similar Documents

Publication Publication Date Title
GR900100137A (en) Novel compositions containing hyaluronic acid associates and a process for preparing same
GB8922018D0 (en) Detergent compositions and process for preparing them
GB8907187D0 (en) Detergent compositions and process for preparing them
PH24897A (en) Detergent compositions and process for preparing them
GB8910087D0 (en) Detergent compositions and process for preparing them
HK142995A (en) Detergent compositions and process for preparing them
GB9005730D0 (en) Solid pharmaceutical composition and a process for preparing same
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
GB2221695B (en) Detergent compositions and process for preparing them
IL110861A (en) Process for preparing pure ethylediaminetetra (methylenphosphonic acid)
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
GB2215720B (en) Process for preparing n-phosphono-methyl-imino-diacetic acid
IL96090A0 (en) Diazabicycloamine compounds,a process for their preparation and compositions containing them
ZA904973B (en) Acaricidal compositions and process for preparing same
HUT54296A (en) Process for producing and utilizing fibre-conditioning compositions containing solved poly-lower-alkylene compound
EP0409331A3 (en) A novel process for the preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
HRP930063B1 (en) Novel compositions containing hyaluronic acid associates and a process for preparing the same
GB8730298D0 (en) Novel aminoalkanoyl-dibenzo(d g)(1 3 6)dioxazocines & process for preparation thereof
GB8921692D0 (en) Process for preparing pure n-methyl-antranilic acid methyl ester
PT84465A (en) Process for preparing a pharmaceutical composition containing (-)-eburnamonine
GB9017605D0 (en) Process for the preparation of a veterinary composition
IL97618A0 (en) Novel benzocycloalkenecarboxylic acid and process for its preparation
SG98794G (en) Detergent compositions and process for preparing them
GB8829346D0 (en) Detergent compositions and process for preparing them
YU171889A (en) Process for preparing glicozilated amides /leu(index 5)/ encephaline

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100219